Market Cap (In SEK)
164.28 Million
Revenue (In SEK)
1.35 Million
Net Income (In SEK)
-44.61 Million
Avg. Volume
40.17 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.0-10.5
- PE
- -
- EPS
- -
- Beta Value
- 1.483
- ISIN
- SE0008216329
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Daniel Schroder
- Employee Count
- -
- Website
- https://www.enorama.se
- Ipo Date
- 2016-06-10
- Details
- Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and allergic rhinitis. The company is based in Malmö, Sweden.
More Stocks
-
300748JL Mag Rare-Earth Co., Ltd.
300748
-
2764Hiramatsu Inc.
2764
-
LOGL
-
CMAUF
-
ADV
-
TIGER
-
CHMBBRW
-
NSHS